Transitions in Care Initiative - Webinar Question and Answer

  1. Can a principal investigator (PI) apply to more than one component?
  2. Are there special considerations for early career researchers in the review process?
  3. For Component 4 will both streams (PHSI & E-Health) launch in both phases of the Team Grants?
  4. Are there targeted funds for new investigators to promote capacity building?
  5. It will indeed be quite challenging to pull strong coordinated applications for the Component 1: Inactivity Summer a summer launch.
  6. Will there be requirements regarding Canada wide participation for example a minimum of more than one province or region?
  7. Can these slides be made available for webinar participants?
  8. In Component 4, could a team not funded in Phase 1 re-submit a revised project in phase 2?
  9. Can you review what defines a health system partner?
  10. Can some of the money be used to support the participation of international collaborators?
  11. Would transitions in care apply to adolescents with mental health concerns transitioning out of the child welfare system?
  12. May trainees apply, or do they need to be in an appointed position by the application date or time funding is released?
  13. Would a systematic review be appropriate for Component 2: Best and Wise Practices Grants?
  14. It appears that Component 1: Inactivity Study is geared more towards observational studies and basic scientists is this correct?
  15. Can you elaborate on the extent to which patient engagement will be required?
  16. If your proposal seems to fit under multiple components, is there a way to determine which component to apply under?
  17. Can you elaborate on what would be a solution for the evaluation grant?
  18. Are there matching funds from health system partners expected for Component 2: Best and Wise Practices Grants?
  19. To confirm, you do not have to have received a Component 2: Best and Wise Practices Grants or Component 3: Evaluation Grant to be eligible for a Component 4: Team Grant?
  20. Would the analysis of barriers and facilitators to implementing a best practice guideline that are not currently implemented be an appropriate topic in Component 2: Best and Wise Practices Grants so long as other competition criteria are met (e.g. changing status and key population)?
  21. Component 2: Best and Wise Practices Grants is a Fall deadline, is it expected to be September or later in the Fall?

  1. Can a principal investigator (PI) apply to more than one component?

    Yes, at this point there are no specific restrictions. PIs may participate in multiple components.

  2. Are there special considerations for early career researchers in the review process?

    At this point there has not been consideration for the addition of early career researchers in the review process. CIHR is committed to capacity-building and recognizes peer-review training as a critical piece of that training.

  3. For Component 4 will both streams (PHSI & E-Health) launch in both phases of the Team Grants?

    Yes, in Phase 1 both streams are set to launch and it is currently expected that Phase 2 will also include both streams in the competition.

  4. Are there targeted funds for new investigators to promote capacity building?

    At CIHR there has been an effort to balance funding for early-career, mid-career and senior investigators. While the current components are not specifically for early-career investigators, training and capacity –building are an integral part of the Initiative.

  5. It will indeed be quite challenging to pull strong coordinated applications for the Component 1: Inactivity Summer a summer launch.

    This component was launched in May with a webinar taking place approximately mid-May providing approximately 4 months to prepare applications. The webinar recording for Component 1 is available via the CIHR Contact Centre and the CIHR Transitions in Care Initiative page under the Component tab.

  6. Will there be requirements regarding Canada wide participation for example a minimum of more than one province or region?

    There is currently no specific requirement; however, proposed activities may act at various levels including municipal, regional and national.

  7. Can these slides be made available for webinar participants?

    Yes, the slides will be made available and emailed to participants in both official languages.

  8. In Component 4, could a team not funded in Phase 1 re-submit a revised project in phase 2?

    Not being funded in Phase 1 of team grants does not prevent application to Phase 2 of team grants.

  9. Can you review what defines a health system partner?

    In the Team Grants (Component 4) the teams are implementing interventions to address transitions in care challenges within a health care delivery environment. A health system partner is a decision-maker who has the authority to make decisions about health policy or the delivery of health services. A decision-maker is typically a health-system manager, policy-maker, or clinician-leader who is in a position to make significant changes to policy or practice.

  10. Can some of the money be used to support the participation of international collaborators?

    The funds must be used in Canada to support Canadian researchers; however, funds can be used to support international collaboration within these restrictions.

  11. Would transitions in care apply to adolescents with mental health concerns transitioning out of the child welfare system?

    Yes

  12. May trainees apply, or do they need to be in an appointed position by the application date or time funding is released?

    No, applicants must be independent investigators as defined by CIHR.

  13. Would a systematic review be appropriate for Component 2: Best and Wise Practices Grants?

    Yes

  14. It appears that Component 1: Inactivity Study is geared more towards observational studies and basic scientists is this correct?

    Yes, while the study can be observational it will mostly be biomedical. There will be a strict countermeasure protocol as only one group will be participating and submitted to the inactivity period under very strict surveillance. The standard countermeasure protocols must therefore be set well in-advance with study designs incorporating the pre-identified protocol.

  15. Can you elaborate on the extent to which patient engagement will be required?

    Patient engagement requirements will be reflected in individual components. For example, the Team Grants Phase 1 will have an emphasis on including patient representation as a team member.

  16. If your proposal seems to fit under multiple components, is there a way to determine which component to apply under?

    The information for each component will become available as the RFAs are launched. The best approach will be to review the detailed RFA launches and participate in specific component webinars.

  17. Can you elaborate on what would be a solution for the evaluation grant?

    Evaluation grants will be designed to evaluate, validate and/or demonstrate the comparative effectiveness of implemented interventions, tools, practices, policies, technologies, programs, and/or other solutions (e.g., federal transfer payment program for mental health and home care, implementation of eHealth technologies, changes to care pathways, etc) for creation of high-quality, pragmatic evidence of relevance to the health system.

    Evaluation of an e-heath solution application, examining the usability or uptake for a particular program or solution. For example an application that assists in navigating patients through specialty care OR recent innovations for patients at discharge (e.g. medication reconciliation initiatives).

  18. Are there matching funds from health system partners expected for Component 2: Best and Wise Practices Grants?

    No. Currently only Component 4 – Team Grants have a minimum 30% partner match requirement with at least half of this being a cash contribution.

  19. To confirm, you do not have to have received a Component 2: Best and Wise Practices Grants or Component 3: Evaluation Grant to be eligible for a Component 4: Team Grant?

    Correct, an applicant does not need to receive TiC funds from Component 2: Best and Wise Practices Grants or Component 3: Evaluation Grants to be eligible for Component 4: Team Grants.

  20. Would the analysis of barriers and facilitators to implementing a best practice guideline that are not currently implemented be an appropriate topic in Component 2: Best and Wise Practices Grants so long as other competition criteria are met (e.g. changing status and key population)?

    Yes. Additional details will become available with the launch of the Component 2: Best and Wise Practices Grants RFA.

  21. Component 2: Best and Wise Practices Grants is a Fall deadline, is it expected to be September or later in the Fall?

    The application deadline for the Component 2: Best and Wise Practices Grants RFA is expected to be earlier in the Fall, but full details will be available with the launch of the funding opportunity.

Date modified: